Dasso International, Inc. v. MOSO North America, Inc.

District Court, D. Delaware·Decided October 27, 2020·No. 1:17-cv-01574·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

DASSO INTERNATIONAL, INC., and EASOON USA, LLC, Plaintiffs,

Civil Action No. 17-1574-RGA v.

MOSO NORTH AMERICA, INC., and MOSO INTERNATIONAL BV, Defendants.

MEMORANDUM ORDER Before me is Plaintiff Dasso International and Plaintiff Easoon USA’s motion for leave to file their Third Amended Complaint. (D.I. 213). I have considered the parties’ briefs on this matter. (D.I. 214, 218, 222). For the reasons set forth below, Plaintiffs’ motion is DENIED. I. BACKGROUND Plaintiffs commenced this action in November 2017, asserting claims of patent infringement and tortious interference with a contract against Defendant MOSO North America (“MOSO NA”). (D.I. 1). At about the same time, Easoon filed a separate action in the Northern District of Georgia against the individuals Brett Kelly, Mark Clifton, and David Osterman (collectively “individual Defendants”), all employees of MOSO NA. (D.I. 1 in No. 19-564). This second action alleged, among other things, breach of fiduciary duty, breach of the duty of loyalty, violation of the Uniform Deceptive Trade Practices Act, misappropriation of trade secrets, tortious interference with business relations, fraud, and civil conspiracy. (Id.). In December 2017, Plaintiffs filed their first amended complaint in this court which added Defendant MOSO International BV (“MOSO BV”), swapped the claim of tortious interference with a contract for tortious interference with prospective economic advantage, and added claims of the violation of Delaware’s Deceptive Trade Practices Act and aiding and abetting the breach of fiduciary duty. (D.I. 10). Plaintiffs filed a Second Amended Complaint in February 2018 adding detail to these claims. (D.I. 19, 25). The deadline to amend the pleadings expired on August 10, 2018. (D.I. 126 at 2). Easoon’s action against Kelly, Clifton, and Osterman was transferred to this Court, and later consolidated with this action on May 7, 2019. (D.I. 124; see D.I. 34 in No. 19-564). Plaintiffs now seek to file a third amended complaint in order add claims of the misappropriation of trade secrets, tortious interference with business relations, and civil conspiracy against the MOSO Defendants. (D.I. 213-1 ¶¶ 151-169). As these claims were only previously alleged against individual MOSO employees Kelly, Clifton, and Osterman, Plaintiffs explain that information learned in depositions in January and February 2020 revealed the “involvement and participation of MOSO.” (D.I. 214 at 6). II. LEGAL STANDARD Federal Rule of Civil Procedure 15(a)(2) states that, apart from amendments as a matter of course, “a party may amend its pleading only with the opposing party’s written consent or the court’s leave. The court should freely give leave when justice so requires.” Fed. R. Civ. P. 15(a)(2). The Third Circuit has construed Rule 15 liberally, instructing that “absent undue or substantial prejudice, an amendment should be allowed under Rule 15(a) unless ‘denial [can] be grounded in bad faith or dilatory motive, truly undue or unexplained delay, repeated failure to cure deficiency by amendments previously allowed or futility of amendment.’” Long v. Wilson, 393 F.3d 390, 400 (3d Cir. 2004) (quoting Lundy v. Adamar of New Jersey, Inc., 34 F.3d 1173, 1196 (3d Cir. 1994)) (emphasis omitted). A request that falls after the court’s deadline to amend must also meet the “good cause” standard of Rule 16(b)(4). Premier Comp Sols. v. UPMC, 970 F.3d 316, 319 (3d Cir. 2020). Rule 16(b)(4) provides, “A schedule may be modified only for good cause and with the judge’s consent.” Fed. R. Civ. P. 16(b)(4). “’Good cause’ exists when the [s]chedule cannot reasonably be met despite the diligence of the party seeking the extension.” ICU Medical, Inc. v. Ryman Techs., Inc., 674 F. Supp. 2d 574, 577 (D. Del. 2009). Unlike Rule 15(a), the Rule 16(b) standard focuses on the “diligence of the movant, and not on prejudice to the non-moving party.” Roquette Freres v. SPI Pharma, Inc., 2009 WL 1444835, at *4 (D. Del. May 21, 2009). The Third Circuit recently clarified that the analysis under Rule 16(b)(4) must precede the Rule 15(a)(2) analysis. Premier Comp Sols., 970 F.3d at 319 (“A party must meet [Rule 16(b)’s] standard before a district court considers whether the party also meets Rule 15(a)’s more liberal standard.”). III. DISCUSSION A. Rule 16(b)(4) Plaintiffs have “forfeited” the Rule 16(b)(4) argument as neither their motion nor their opening brief even mention Rule 16(b)(4). See id. Plaintiffs rely heavily on the fact that they have complied with the Amended Scheduling Order I entered on March 3, 2020, to demonstrate diligence and good cause under Rule 16(b)(4). (D.I. 209; D.I. 214 at 9-10; D.I. 222 at 5). This scheduling order extended all deadlines in the case by approximately three months and acknowledged the fact that the parties were “concurrently discussing proposed amendments to the pleadings.” (D.I. 209 at 3-4). However, this order did not alter the deadline to amend the pleadings, which passed in August 2018. (D.I. 126 at 2). As such, Plaintiffs’ compliance with the amended schedule will not demonstrate due diligence per Rule 16(b)(4) if the proposed amendments should have been brought at an earlier stage in the litigation. The burden is on the Plaintiffs to demonstrate due diligence. Race Tires Am. Inc. v. Hoosier Racing Tire Corp., 614 F.3d 57, 86 (3d Cir. 2010). The crux of Plaintiffs’ argument is that new information surfaced in depositions taken this past January and February that established MOSO’s involvement in the “theft and usage of Easoon’s trade secrets and proprietary information.” (D.I. 214 at 9). Plaintiffs assert that their claims against MOSO were confirmed by the discovery of various private emails and a Dropbox folder that allowed Kelly, Osterman, and Clifton to transmit Easoon data to MOSO while they were still employed with Easoon. (D.I. 214 at 7-8; D.I. 222 at 8). Until these depositions, the discovery of the extent of MOSO’s involvement was apparently delayed by previous conflicting deposition testimony of Defendant Brett Kelly, the current CEO of MOSO NA. (D.I. 222 at 5-7, Ex. 1 at 2:23-3:1). Defendants reply that Plaintiffs cannot demonstrate due diligence because the claims contained in the proposed amendments “would have been self-evident” upon filing the Second Amended Complaint in February 2018. (D.I. 218 at 2). I agree with Defendants. Both sides acknowledge that Plaintiffs are seeking to add claims that are not “new” to this litigation but are merely new to Defendants MOSO NA and MOSO BV (collectively “MOSO”). (D.I. 214 at 5; D.I. 218 at 2). However, Plaintiffs’ contention that they only recently became aware of the extent of MOSO’s involvement sufficient to plead the (1) misappropriation of trade secrets; (2) tortious interference with business relations; and (3) a civil conspiracy involving Defendants Kelly, Osterman, and Clifton, is unpersuasive given their previous pleadings. (D.I. 214 at 4-5). In their Second Amended Complaint, Plaintiffs describe significant involvement from MOSO in the activities of the individual Defendants.

Free access — add to your briefcase to read the full text and ask questions with AI

Dasso International, Inc. v. MOSO North America, Inc., (D. Del. 2020).

Dasso International, Inc. v. MOSO North America, Inc. (Dasso International, Inc. v. MOSO North America, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related